Dr. Joao de Quevedo with UTHealth Houston shares what researchers found during a clinical trial for Spravato, the first FDA-approved nasal spray to treat depression.
Scientists from QUT revealed how Cycloseris cyclolites, a free-living mushroom coral species, respond to specific types of light.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback